1. PharmaCo is advertising a drug it has recently released to the market. The drug, Aionios, has been shown to lead to a 40% reduction in the occurrence of heart attacks in men older than 50. The rate of heart attacks in this population group and in the control group during testing) was 2% per year. Question 1: What are the absolute risk reduction (ARR), relative risk reduction (RRR), and number needed to treat (NNT) for the drug